• Learning Objective 1:  Understand that disease-modifying therapies can be applied to the treatment or prevention of type 1 diabetes.
  • Learning Objective 2:  Understand that type 1 diabetes can be accurately identified in the presymptomatic phase.
  • Learning Objective 3:  Understand that measures of beta cell dysfunction can inform type 1 diabetes prediction and interventions.
Session date: 
10/06/2022 - 12:00pm to 1:00pm CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Emily Sims, MD